Pharmacology and Therapeutics of Bronchodilators
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ahrens, 1990, Skeletal muscle tremor and the influence of adrenergic drugs, J Asthma, 27, 11, 10.3109/02770909009073289
Aizawa, 1991, Effects of procaterol, a β2-adrenoceptor stimulant, on neuroeffector transmission in human bronchial tissue, Respiration, 58, 163, 10.1159/000195919
Anderson, 1986, Hemodynamic and non-bronchial effects of ipratropium bromide, Am J Med, 81, 45, 10.1016/0002-9343(86)90461-4
Aparici, 2010, The in vitro pharmacological profile of LAS100977—a potent, selective and long-acting beta-2 receptor agonist (Abstract), Am J Respir Crit Care Med, 181, A5675
Aronson JK (2006) Theophylline, in Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 15th ed ( Aronson JK ed) pp 3361–3371, Elsevier Science, Amsterdam.
Backer, 2007, Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?, Scand J Med Sci Sports, 17, 615, 10.1111/j.1600-0838.2007.00711.x
Balint, 2010, Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone, Int J Chron Obstruct Pulmon Dis, 5, 311
Barrett, 2010, In vitro pharmacological characterisation of GW642444, a novel long acting β2-agonist (LABA) using human recombinant β1/2/3 adrenoceptor cAMP assays (Abstract), Am J Respir Crit Care Med, 181, A4451
Barrett, 2010, Pharmacological characterisation of GW642444, a long-acting β2-agonist (LABA) with rapid onset and long duration, on isolated large and small human airways (Abstract), Am J Respir Crit Care Med, 181, A4453
Barrington KJ Finer NN (2007) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev (3):CD000509.
Bateman, 2008, Carmoterol—safety and tolerability of a long-acting β2 agonist in patients with COPD (Abstract), Proc Am Thorac Soc, 5, A653
Beeh, 2011, Once-daily NVA237 improves exercise endurance from first dose in patients with COPD: the GLOW3 trial (Abstract), Eur Respir J, 38, 819s
Beier, 2010, Efficacy and safety of single doses of inhaled LAS100977 in patients with persistent asthma (Abstract), Am J Respir Crit Care Med, 181, A5414
Berger, 2003, Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma, Ann Allergy Asthma Immunol, 90, 583, 10.1016/S1081-1206(10)61859-5
Bouyssou, 2011, Synergistic bronchoprotective activity of the long-acting beta2-agonist olodaterol with tiotropium (long-acting M3 antagonist) and ciclesonide (inhaled steroid) on the ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs (Abstract), Eur Respir J, 38, 613s
Bouyssou, 2010, Addition of the new once-daily LABA BI 1744 to tiotropium results in superior bronchoprotection in pre-clinical models (Abstract), Am J Respir Crit Care Med, 181, A4445
Brown, 2011, Effect of olodaterol on the relaxation of small airways (Abstract), Eur Respir J, 38, 308s
Brunnée, 1992, Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma, Eur Respir J, 5, 982, 10.1183/09031936.93.05080982
Bullowa, 1903, On the hypodermic use of adrenalin chloride in the treatment of asthmatic attacks, Med News, 83, 787
Burniston, 2007, Anabolic effects of a non-myotoxic dose of the β2-adrenergic receptor agonist clenbuterol on rat plantaris muscle, Muscle Nerve, 35, 217, 10.1002/mus.20684
Caccia, 1984, Kinetics and distribution of the beta-adrenergic agonist salbutamol in rat brain, J Pharm Pharmacol, 36, 200, 10.1111/j.2042-7158.1984.tb06941.x
Canepa-Anson, 1987, Differences between acute and long-term metabolic and endocrine effects of oral β-adrenoceptor agonist therapy with pirbuterol for cardiac failure, Br J Clin Pharmacol, 23, 173, 10.1111/j.1365-2125.1987.tb03026.x
Carstairs, 1985, Autoradiographic visualization of betaadrenoceptor subtypes in human lung, Am Rev Respir Dis, 132, 541
Castro, 2011, A new nitrosyl ruthenium complex nitric oxide donor presents higher efficacy than sodium nitroprusside on relaxation of airway smooth muscle, Eur J Pharm Sci, 43, 370, 10.1016/j.ejps.2011.05.004
Cates CJ Cates MJ (2008) Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (3):CD006363.
Cates CJ Lasserson TJ Jaeschke R (2009) Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2):CD006924.
Cazzola, 2009, Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD, Curr Opin Investig Drugs, 10, 482
Cazzola, 1999, Long acting β2 agonists and theophylline in stable chronic obstructive pulmonary disease, Thorax, 54, 730, 10.1136/thx.54.8.730
Cazzola, 2002, Onset of action following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway obstruction, Pulm Pharmacol Ther, 15, 97, 10.1006/pupt.2001.0336
Cazzola, 2006, The role of combination therapy with corticosteroids and long-acting β2-agonists in the prevention of exacerbations in COPD, Int J Chron Obstruct Pulmon Dis, 1, 345
Cazzola, 2010, Arformoterol tartrate in the treatment of COPD, Expert Rev Respir Med, 4, 155, 10.1586/ers.10.16
Cazzola, 2010, Roflumilast in chronic obstructive pulmonary disease: evidence from large trials, Expert Opin Pharmacother, 11, 441, 10.1517/14656560903555201
Cazzola, 2010, Indacaterol for chronic obstructive pulmonary disease (COPD), Drugs Today (Barc), 46, 139, 10.1358/dot.2010.46.3.1450070
Chapman, 2010, Pharmacology of SCH900182, a potent, selective inhibitor of PDE4 for inhaled administration (Abstract), Am J Respir Crit Care Med, 181, A5671
Cheung, 1998, Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo, Am J Respir Crit Care Med, 158, 792, 10.1164/ajrccm.158.3.9801036
Choi, 2007, The effect of tiotropium and inhaled corticosteroid combination therapy in chronic obstructive pulmonary disease (COPD) and chronic obstructive bronchial asthma (COBA) associated with irreversible pulmonary function (Abstract), Am J Respir Crit Care Med, 175, A130
Collomp, 2000, Effects of short-term oral salbutamol administration on exercise endurance and metabolism, J Appl Physiol, 89, 430, 10.1152/jappl.2000.89.2.430
Conner, 1984, Mapping of β-adrenergic receptors in rat lung: effect of isoproterenol, Exp Lung Res, 6, 91, 10.3109/01902148409087898
Cope, 2011, Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease—a network meta-analysis, Int J Chron Obstruct Pulmon Dis, 6, 329, 10.2147/COPD.S18759
Coughlin, 1995, Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study, Am J Epidemiol, 142, 395, 10.1093/oxfordjournals.aje.a117647
Danto, 2007, A randomized, double-blind, placebo-controlled, parallel group, six-week study of the efficacy and safety of tofimilast dry powder for inhalation (DPI) in adults with COPD (Abstract), Am J Respir Crit Care Med, 175, A131
Decramer, 2011, Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation, in COPD (Abstract), Eur Respir J, 38, 150s
de Mey, 2011, No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study, BMC Clin Pharmacol, 11, 7, 10.1186/1472-6904-11-7
De Troyer, 1978, Influence of beta-2 agonists on pressure-volume characteristics of the lungs, Am Rev Respir Dis, 118, 987
Dixon, 1983, Changes in the bronchial reactivity of dogs caused by exposure to sulphur dioxide, J Physiol, 337, 89, 10.1113/jphysiol.1983.sp014613
Ducharme FM Ni Chroinin M Greenstone I Lasserson TJ (2010a) Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (4):CD005533.
Ducharme FM Ni Chroinin M Greenstone I Lasserson TJ (2010b) Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (4):CD005535.
Du Plooy, 1994, The dose-related hyper- and hypokalaemic effects of salbutamol and its arrhythmogenic potential, Br J Pharmacol, 111, 73, 10.1111/j.1476-5381.1994.tb14025.x
Easton, 1986, A comparison of the bronchodilating effects of a β2-adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence, N Engl J Med, 315, 735, 10.1056/NEJM198609183151205
Edner, 1989, Effect of salbutamol on digoxin concentration in serum and skeletal muscle, Eur J Clin Pharmacol, 36, 235, 10.1007/BF00558153
Elkout, 2010, Use and safety of long-acting β2-agonists for pediatric asthma, Pediatric Health, 4, 295, 10.2217/phe.10.31
Ellis, 1997, Role of soluble guanylyl cyclase in the relaxations to a nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea and human bronchus, J Pharmacol Exp Ther, 280, 1215
Ellis, 1976, Pharmacokinetics of theophylline in children with asthma, Pediatrics, 58, 542, 10.1542/peds.58.4.542
Ellis, 1995, Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle, Br J Pharmacol, 116, 2510, 10.1111/j.1476-5381.1995.tb15103.x
Emala, 1997, Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle, Am J Physiol, 272, L745
El-Tawil S Al Musa T Valli H Lunn MP El-Tawil T Weber M (2010) Quinine for muscle cramps. Cochrane Database Syst Rev (12):CD005044
Ford, 2010, In vitro and in vivo pharmacological characterisation of GW642444, a novel long-acting β2 agonist (LABA), with fast onset and long duration in the guinea-pig (Abstract), Am J Respir Crit Care Med, 181, A5677
Ford, 2010, The therapeutic index of vilanterol trifenatate (Abstract), Eur Respir J, 24, 208s
Formgren, 1970, A clinical comparison of inhaled terbutaline and orciprenaline in asthmatic patients, Scand J Respir Dis, 51, 203
Fox, 2007, Oral or inhaled corticosteroid combination therapy with low dose theophylline reverses corticosteroid insensitivity in a smoking mouse model (Abstract), Proc Am Thorac Soc, 2, A637
Freedman, 1972, Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol, Br J Dis Chest, 66, 222, 10.1016/0007-0971(72)90033-2
Freeman, 1992, The effect of ipratropium bromide on maximal exercise capacity in asthmatic and non-asthmatic men, Respir Med, 86, 151, 10.1016/S0954-6111(06)80232-5
Fugleholm, 1993, Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma, Eur Respir J, 6, 1474, 10.1183/09031936.93.06101474
Gandevia, 1975, Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders, Postgrad Med J, 51, 13
Gelb, 2011, ACCORD COPD I: Twice-daily aclidinium bromide improves quality of life and dyspnea in COPD patients (Abstract), Eur Respir J, 38, 149s
Gershon, 2011, Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study, Ann Intern Med, 154, 583, 10.7326/0003-4819-154-9-201105030-00003
Glossop, 2010, Inhalation by design: novel ultra-long-acting β2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup, J Med Chem, 53, 6640, 10.1021/jm1005989
Gongora, 1991, A single dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects, Am Rev Respir Dis, 144, 626, 10.1164/ajrccm/144.3_Pt_1.626
Gray, 1982, A comparative double-blind study of the bronchodilator effects and side effects of inhaled fenoterol and terbutaline administered in equipotent doses, Br J Dis Chest, 76, 341, 10.1016/0007-0971(82)90068-7
Green, 1996, Sustained activation of a G protein-coupled receptor via “anchored” agonist binding. Molecular localization of the salmeterol exosite within the β2-adrenergic receptor, Biol Chem, 271, 24029, 10.1074/jbc.271.39.24029
Greenough, 1993, Inhaled ipratropium bromide and terbutaline in asthmatic children, Respir Med, 87, 111, 10.1016/0954-6111(93)90137-O
Gryglewski, 1970, The inactivation of noradrenaline and isoprenaline in dogs, Br J Pharmacol, 39, 573, 10.1111/j.1476-5381.1970.tb10365.x
Gu Q Lee LY (2006) Neural control of airway smooth muscle, in Encyclopedia of Respiratory Medicine ( Laurent GJ Shapiro SD eds) pp 138–145, Elsevier, Amsterdam.
Gutke, 2005, AWD-12-281 (inhaled) (elbion/GlaxoSmithKline), Curr Opin Investig Drugs, 6, 1149
Haalboom, 1985, Hypokalaemia induced by inhalation of fenoterol, Lancet, 1, 1125, 10.1016/S0140-6736(85)92432-8
Haeussermann, 2006, Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD (Abstract), Eur Respir J, 28, 211s
Hamad, 1997, Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle, Am J Physiol, 273, L807
Hanania NA Feldman G Zachgo W Shim JJ Crim C Sanford L Lettis S Barnhart F Haumann B (2012) The efficacy and safety of the novel long-acting β2 agonist vilanterol in COPD patients: a randomized placebo-controlled trial. Chest http://dx.doi.org/10.1378/chest.11-2231 .
Hardy, 1992, Bronchodilation effect of oxitropium bromide compared with ipratropium bromide (Abstract), Thorax, 48, 865
Herrmann, 1937, Successful treatment of persistent extreme dyspnea, ‘status asthmaticus’—Use of theophylline ethylene diamine (aminophylline, U.S.P.) intravenously, J Lab Clin Med, 23, 135
Hirsch, 1922, Klinischer und Experimenteller Beitrag zur KrampRosenden wirkung der purinderivate, Klinische Wochenschrift, 1, 61, 10.1007/BF01714150
Hodder, 2007, Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids, Int J Chron Obstruct Pulmon Dis, 2, 157
Hughes, 2011, Dual-pharmacology muscarinic antagonist and β2 agonist molecules for the treatment of chronic obstructive pulmonary disease, Bioorg Med Chem Lett, 21, 1354, 10.1016/j.bmcl.2011.01.043
Hulland, 2011, Duration of ingle and dual pharmacology in vivo of PF-4348235: a novel inhaled dual antimuscarinic/ß2 agonist in conscious guinea pigs (Abstract), Am J Respir Crit Care Med, 183, A1610
Ida, 1976, Cardiorespiratory activities of 3-formylamino-4-hydroxy-α-(N-1-methyl-2-p-methoxyphenethylaminomethyl)-benzylalcohol-hemifumarate (BD 40A) and some other β-adrenoceptor stimulants in conscious guinea pigs, Arzneimittelforschung, 26, 1337
Ida, 1976, Comparison of the action of BD 40 A and some other β-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig, Arzneimittelforschung, 26, 839
Inman, 1996, The effect of regular inhaled albuterol on exercise-induced bronchoconstriction, Am J Respir Crit Care Med, 153, 65, 10.1164/ajrccm.153.1.8542164
Inoue, 2009, Investigation of β2-adrenoceptor subtype selectivity and organ specificity for bedoradrine (KUR-1246), a novel tocolytic β-adrenergic receptor stimulant, J Obstet Gynaecol Res, 35, 405, 10.1111/j.1447-0756.2008.01001.x
Ito, 2001, Possible involvement of Rho kinase in Ca2+ sensitization and mobilization by MCh in tracheal smooth muscle, Am J Physiol Lung Cell Mol Physiol, 280, L1218, 10.1152/ajplung.2001.280.6.L1218
Jackson, 2010, “Divine stramonium”: the rise and fall of smoking for asthma, Med Hist, 54, 171, 10.1017/S0025727300000235
Jansat, 2009, Safety and pharmacokinetics of single doses of aclidiniium bromide, a novel long-acting antimuscarinic in healthy subjects, Int J Clin Pharmacol Ther, 47, 460, 10.5414/CPP47460
Jenne, 1998, Can oral β2 agonists cause heart failure, Lancet, 352, 1081, 10.1016/S0140-6736(05)79750-6
Johnson, 1998, The β-adrenoceptor, Am J Respir Crit Care Med, 158, S146, 10.1164/ajrccm.158.supplement_2.13tac110
Jones, 2011, Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD, Bioorg Med Chem Lett, 21, 2759, 10.1016/j.bmcl.2010.10.132
Jones, 2011, Aclidinium bromide in patients with chronic obstructive pulmonary disease: efficacy and safety results from ATTAIN (Abstract), Am J Respir Crit Care Med, 183, A6350
Jones, 1990, Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca++-activated K+ channel inhibitor, J Pharmacol Exp Ther, 255, 697
Källström, 1994, The interaction between salmeterol and β2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro, Br J Pharmacol, 113, 687, 10.1111/j.1476-5381.1994.tb17047.x
Kanniess, 2008, Acute effect of carmoterol, a long-acting β2-agonist, in patients with COPD (Abstract), Proc Am Thorac Soc, 5, A655
Kapoor, 2009, The efficacy of tiotropium as a steroid-sparing agent in severe asthma, Can Respir J, 16, 99, 10.1155/2009/206506
Kelleher, 2011, Phase II study of once-daily GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD) (Abstract), Eur Respir J, 38, 140s
Kempsford, 2011, The safety, tolerability, pharmacodynamics and pharmacokinetics of inhaled fluticasone furoate (FF) and vilanterol (VI) are unaffected by administration in combination (Abstract), Eur Respir J, 38, 138s
Kempsford, 2010, GW642444, a novel inhaled long-acting β2 adrenoceptor agonist (LABA), at single doses of 25, 50 and 100mcg, is well tolerated and demonstrates prolonged bronchodilation in asthmatic patients (Abstract), Am J Respir Crit Care Med, 181, A5413
Kempsford, 2010, GW642444, a novel inhaled long-acting β2 adrenoceptor agonist (LABA), at single doses of 25, 50 and 100mcg, is well tolerated and demonstrates prolonged bronchodilation in COPD patients (Abstract), Am J Respir Crit Care Med, 181, A4447
Kerwin, 2011, ACCORD COPD I: Improvements in nighttime symptoms and rescue medication use in COPD with twice-daily aclidinium bromide (Abstract), Eur Respir J, 38, 149s
Kikis, 1982, Influence of ipratropium bromide on heart rate and hemodynamics in patients with sinus bradycardia, Clin Cardiol, 5, 441, 10.1002/clc.4960050804
Kikkawa, 1994, TA-2005, a novel, long-acting and selective β2-adrenocepter agonist: characterization of its in vivo bronchodilating action in guinea pigs and cats in comparison with other β2-agonists, Biol Pharm Bull, 17, 1047, 10.1248/bpb.17.1047
Kikkawa, 1991, Tracheal relaxing effects and β2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea-pig tissues, Jpn J Pharmacol, 57, 175, 10.1254/jjp.57.175
Kizer, 1999, Blurred vision from ipratropium bromide inhalation, Am J Health Syst Pharm, 56, 914, 10.1093/ajhp/56.9.914a
Knudson, 1967, An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects, J Appl Physiol, 22, 402, 10.1152/jappl.1967.22.3.402
Kossel, 1888, Uber eine neue Base aus dem Pflanzenreich, Berichte der Deutschen chemischen Gesellschaft, 21, 2164, 10.1002/cber.188802101422
Kottakis, 2006, Efficacy of the novel very long-acting β2-agonist carmoterol following 7 days once daily dosing: comparison with twice daily formoterol in patient with persistent asthma (Abstract), Eur Respir J, 28, 665s
Kuna, 2011, Efficacy and safety of AZD3199, an inhaled ultra long-acting β2-agonist, in patients with COPD (Abstract), Eur Respir J, 38, 148s
LaForce, 2008, Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study, Allergy, 63, 103, 10.1111/j.1398-9995.2007.01555.x
Lainé, 2011, The pre-clinical pharmacology of the inhaled muscarinic antagonist GSK573719 predicts once-daily clinical dosing (Abstract), Eur Respir J, 38, 613s
Levenson M (2008) Long-acting beta-agonists and adverse asthma events meta-analysis. Statistical briefing package for joint meeting of the FDA Pulmonary-Allergy Drugs Advisory Committee, Drug Safety and Risk Management Advisory Committee and Pediatric Advisory Committee, December 2008. Available at http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01-FDA.pdf .
Li, 2009, Pharmacokinetics of PF-00610355, a novel inhaled long-acting β2-adrenoreceptor agonist (Abstract), Eur Respir J, 34, 777s
Libersa, 1988, Comparative cardiac effects of intravenous bolus of ipratropium bromide (itrop) and atropine sulfate in 22 patients, Clin Cardiol, 11, 454, 10.1002/clc.4960110704
Littner, 2000, Long acting bronchodilation with once daily dosing of tiotropium (Spiriva) in stable chronic obstructive disease, Am J Respir Crit Care Med, 161, 1136, 10.1164/ajrccm.161.4.9903044
Lötvall, 2010, Safety and efficacy of fluticasone furoate/vilanterol trifenatate in COPD patients (Abstract), Eur Respir J, 24, 1013s
Lötvall, 2010, Dose-related efficacy of vilanterol trifenatate, a long-acting beta2 agonist with inherent 24-hour activity, in patients with persistent asthma (Abstract), Eur Respir J, 24, 1013s
Macht, 1921, A study of antispasmodic drugs on the bronchus, J Pharmacol Exp Ther, 18, 373
Macintyre, 2009, A randomised, double-blind study to determine the duration of action of lung pharmacodynamics by plethysmography (sGaw) of a β2 adrenoreceptor agonist, PF-00610355 (Abstract), Eur Respir J, 34, 344s
Magnussen, 1987, Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics, Am Rev Respir Dis, 136, 1163, 10.1164/ajrccm/136.5.1163
Mahler, 2011, Combining once-daily bronchodilators in COPD: indacaterol plus tiotropium versus tiotropium alone (Abstract), Am J Respir Crit Care Med, 183, A1591
Make, 2008, Efficacy of 3 different doses of carmoterol, a long-acting β2-agonist in patients with COPD (Abstract), Proc Am Thorac Soc, 5, A961
Malani, 1982, Ipratropium bromide induced angle closure glaucoma, N Z Med J, 95, 749
Maltais, 2010, Four weeks once daily treatment with tiotropium+olodaterol (BI 1744) fixed dose combination compared with tiotropium in COPD patients (Abstract), Eur Respir J, 24, 1014s
Maltin, 1993, Effect of protease inhibitors and clenbuterol on the in vitro degradation of dystrophin by endogenuous proteases in human skeletal muscle, Biosci Rep, 13, 159, 10.1007/BF01149960
Marshall, 2010, The effect of different dosages of caffeine on time to exhaustion in prolonged exercise in trained athletes (a meta analysis), The Plymouth Student Scientist, 3, 18
Maspero, 2010, Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma, J Asthma, 47, 1106, 10.3109/02770903.2010.514634
Mazza, 1982, Xanthines in respiratory diseases, Can Fam Physician, 28, 1799
McDaniel, 1992, Nitrovasodilators relax arterial smooth muscle by decreasing [Ca2+]i and uncoupling stress from myosin phosphorylation, Am J Physiol, 263, C461, 10.1152/ajpcell.1992.263.2.C461
McNamara, 2009, Comparative preclinical efficacy of combivent and a novel, bifunctional muscarinic antagonist and β2-adrenergic agonist (Abstract), Am J Respir Crit Care Med, 179, A4573
Mehta, 2011, Safety, tolerability and pharmacokinetics (PK) of repeated doses of GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in healthy adults (Abstract), Eur Respir J, 38, 723s
Mehta, 2011, Safety, pharmacokinetics (PK) and pharmacodynamics (PD) of single doses of GSK573719 inhalation powder, a new long-acting muscarinic antagonist (LAMA), in patients with COPD (Abstract), Eur Respir J, 38, 138s
Meurs, 2011, The bronchoprotective efect of olodaterol against histamine is synergistically enhanced and prolonged by tiotropium bromide (Abstract), Am J Respir Crit Care Med, 183, A1379
Miller, 1980, A comparison of oral terbutaline and fenoterol in asthma, Ann Allergy, 44, 15
Miraldi, 2001, Distribution of hyoscyamine and scopolamine in Datura stramonium, Fitoterapia, 72, 644, 10.1016/S0367-326X(01)00291-X
Miralpeix, 2010, LAS100977, a novel β2-agonist, has a longer duration of action and a more favourable therapeutic index than salmeterol in anaesthetised dogs (Abstract), Eur Respir J, 24, 218s
Molimard, 1998, Long- and short-acting β2 adrenoceptor agonists: interactions in human contracted bronchi, Eur Respir J, 11, 583, 10.1183/09031936.98.11030583
Moore, 2011, Influence of gene–gene interactions on response to albuterol therapy, Pharmacogenomics, 12, 1, 10.2217/pgs.10.192
Naline, 2010, β2 agonist intrinsic activity: comparison of BI 1744 and formoterol in different functional settings (Abstract), Am J Respir Crit Care Med, 181, A4443
Naline, 1994, Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus, Eur Respir J, 7, 914, 10.1183/09031936.94.07050914
Nandeuil, 2006, Safety and tolerability of the novel very long acting β2-agonist carmoterol given as a 2 μg qd dose; 8 days comparison with formoterol and placebo in patients with persistent asthma (Abstract), Eur Respir J, 28, 665s
Nannini LJ Cates CJ Lasserson TJ Poole P (2007a) Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4):CD006826.
Nannini LJ Cates CJ Lasserson TJ Poole P (2007b) Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4):CD006829.
Nannini LJ Cates CJ Lasserson TJ Poole P (2007c) Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4):CD003794.
Nardi, 2008, Potassium channels as drug targets for therapeutic intervention in respiratory diseases, Expert Opin Ther Pat, 18, 1361, 10.1517/13543770802553798
Newnham, 1991, The effects of frusemide and triamterene on the hypokalaemic and electrocardiographic responses to inhaled terbutaline, Br J Clin Pharmacol, 32, 630, 10.1111/j.1365-2125.1991.tb03965.x
Nicholson, 1994, Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes—their potential utility in the therapy of asthma, Pulm Pharmacol, 7, 1, 10.1006/pulp.1994.1001
Norman, 2009, Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119, Expert Opin Ther Pat, 19, 1157, 10.1517/13543770902815527
Norris, 2011, The pharmacodynamics of GSK961081 in patients with COPD (Abstract), Eur Respir J, 38, 138s
O'Donnell, 1994, Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis, J Pharmacol Exp Ther, 270, 1289
O'Donnell, 1978, Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on β-adrenoceptors in guinea-pig trachea, Eur J Clin Pharmacol, 47, 333, 10.1016/0014-2999(78)90241-8
Ohmori, 2004, Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532), Regul Pept, 123, 201, 10.1016/j.regpep.2004.04.029
Oksuz, 2007, Acute angle-closure glaucoma precipitated by local tiotropium absorption, Pulm Pharmacol Ther, 20, 627, 10.1016/j.pupt.2006.07.002
Oleson, 2010, ALKS 27 (Trospium inhalation powder) improves lung function following single administration in subjects with COPD (Abstract), Am J Respir Crit Care Med, 181, A4457
Onoue, 2007, Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD, Peptides, 28, 1640, 10.1016/j.peptides.2007.04.009
Page, 1993, An explanation of the asthma paradox, Am Rev Respir Dis, 147, S29, 10.1164/ajrccm/147.6_Pt_2.S29
Pahl, 2006, Synergistic effects of the anti-cholinergic R,R-glycopyrrolate with anti-inflammatory drugs, Biochem Pharmacol, 72, 1690, 10.1016/j.bcp.2006.07.025
Palmqvist, 1999, Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients, Am J Respir Crit Care Med, 160, 244, 10.1164/ajrccm.160.1.9901063
Patel, 2011, The in-vitro pharmacology of PF-4348235 at native receptors—a novel inhaled dual antimuscarinic/beta2 adrenoceptor agonist (Abstract), Am J Respir Crit Care Med, 183, A1608
Patel, 2010, The in vitro pharmacology of PF-3429281—A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist (Abstract), Eur Respir J, 24, 218s
Patel, 2010, The in vitro pharmacology of PF-4522971—A novel inhaled muscarinic M3 antagonist (Abstract), Eur Respir J, 36, 219s
Paul, 2010, Revisiting an old therapy: theophylline in asthma, J Asthma Allergy Educ, 1, 180, 10.1177/2150129710372963
Penna, 1993, Systemic absorption of salbutamol following nebulizer delivery in acute asthma, Acta Pediatr, 82, 963, 10.1111/j.1651-2227.1993.tb12609.x
Persson, 1991, Pharmacology of anti-asthma xanthenes, Handb Exp Pharmacol, 98, 207, 10.1007/978-3-642-75855-3_7
Philip, 2010, Demonstration of dual pharmacology in vivo of PF-3429281: a novel inhaled dual antimuscarinic/β2 agonist (Abstract), Eur Respir J, 24, 218s
Physician's Desk Reference (1998) Medical Economics Company, Montvale, NJ.
Plotnick LH Ducharme FM (2000) Combined inhaled anticholinergic agents and beta-2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev (2):CD000060.
Poli, 2009, harmacokinetic and pharmacodynamic interaction of carmoterol and budesonide in asthmatic patients (Abstract), Am J Respir Crit Care Med, 179, A2789
Pras, 1991, Urinary retention associated with ipratropium bromide, DICP, 25, 939, 10.1177/106002809102500907
Profita, 2011, β2 long-acting and anticholinergic drugs synergistically control TGFβ1-mediated neutrophilic inflammation in COPD: an “in vitro” model (Abstract), Eur Respir J, 38, 694s
Pulido-Rios, 2009, TD-5959: a novel bifunctional muscarinic antagonist–β2-adrenergic agonist with potent and sustained in vivo bronchodilator activity in guinea pigs (Abstract), Am J Respir Crit Care Med, 179, A6195
Pullerits, 2011, The duration of bronchodilation of salmeterol and salbutamol as measured by specific airway conductance in healthy subjects, Pulm Pharmacol Ther, 24, 55, 10.1016/j.pupt.2010.10.006
Ramsdale, 1991, Prolonged protection against methacholine-induced bronchoconstriction by the inhaled β2-agonist formoterol, Am Rev Respir Dis, 143, 998, 10.1164/ajrccm/143.5_Pt_1.998
Renard, 2011, Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches, Respir Res, 12, 54, 10.1186/1465-9921-12-54
Restrepo, 2007, Use of inhaled anticholinergic agents in obstructive airway disease, Respir Care, 52, 833
Richardson, 1976, Nonadrenergic inhibitory nervous system in human airways, J Appl Physiol, 41, 764, 10.1152/jappl.1976.41.5.764
Rider, 2006, A safety review of long-acting β2-agonists in patients with asthma, J Am Osteopath Assoc, 106, 562
Riiser, 2006, The effect of formoterol inhalation on endurance performance in hypobaric conditions, Med Sci Sports Exerc, 38, 2132, 10.1249/01.mss.0000233801.46906.9b
Rossing, 2008, Carmoterol does not induce tolerance in COPD (Abstract), Proc Am Thorac Soc, 5, A962
Ruffin, 1982, Assessment of β-adrenoceptor antagonists in asthmatic patients, Br J Clin Pharmacol, 13, 325S, 10.1111/j.1365-2125.1982.tb01937.x
Salama, 2011, Advances in drug delivery: is triple therapy the future for the treatment of chronic obstructive pulmonary disease?, Expert Opin Pharmacother, 12, 1913, 10.1517/14656566.2011.589837
Salter, 1859, On some points in the treatment and clinical history of asthma, Edinburgh Med J, 4, 1109
Santus, 2007, Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting β2-agonists, Respir Med, 101, 1798, 10.1016/j.rmed.2007.02.007
Scarpace, 1988, Increased beta-adrenergic receptors in the light-density membrane fraction in lungs from senescent rats, J Gerontol, 43, B163, 10.1093/geronj/43.6.B163
Scheinin, 1987, Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers, Br J Clin Pharmacol, 24, 645, 10.1111/j.1365-2125.1987.tb03224.x
Schering Corporation (2010) Foradil Aerolizer (formoterol fumarate). U.S. prescribing information. Available at http://www.spfiles.com/piforadil.pdf .
Schnapp, 2009, In vitro characterization of BI 1744 CL, a novel long acting β2 agonist: investigations to understand its long duration of action (Abstract), Am J Respir Crit Care Med, 179, A1919
Schultze-Werninghaus, 1982, The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S. R. Hirsch in Frankfurt (Main) 1922, Clin Allergy, 12, 211, 10.1111/j.1365-2222.1982.tb01641.x
Scullion, 2007, The development of anticholinergics in the management of COPD, Int J Chron Obstruct Pulmon Dis, 2, 33
Sears, 2011, The addition of long-acting beta-agonists to inhaled corticosteroids in asthma, Curr Opin Pulm Med, 17, 23, 10.1097/MCP.0b013e328341004c
Shibata, 2000, Teratogenic and fetal toxicity following intravenous theophylline administration in pregnant rabbits is related to maternal drug plasma levels, Methods Find Exp Clin Pharmacol, 22, 101, 10.1358/mf.2000.22.2.796072
Sichletidis, 1999, Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD, Int J Clin Pract, 53, 185, 10.1111/j.1742-1241.1999.tb11699.x
Simons, 1987, Anticholinergic drugs and the airways: “time future contained in time past”, J Allergy Clin Immunol, 80, 239, 10.1016/0091-6749(87)90025-X
Singh, 2011, Efficacy and safety of nebulized glycopyrrolate (EP-101) for administration using high efficiency nebulizer in patients with COPD (Abstract), Eur Respir J, 38, 147s
Skoogh, 1986, Parasympathetic ganglia in the airways, Bull Eur Physiopathol Respir, 22, 143
Skorodin, 1986, Oxitropium bromide, a new anticholinergic bronchodilator, Ann Allergy, 56, 229
Smith, 1984, Metabolic responses to beta 2 stimulants, J R Coll Physicians Lond, 18, 190
Sousa, 2011, Sildenefil decreases rat tracheal hyperresponsiveness to carbochol and changes canonical transient receptor potential gene expression after antigen challenge, Braz J Med Biol Res, 44, 562, 10.1590/S0100-879X2011000600010
Spina, 1995, Regulation by phosphodiesterase isoenzymes of non-adrenergic non-cholinergic contraction in guinea-pig isolated main bronchus, Br J Pharmacol, 116, 2334, 10.1111/j.1476-5381.1995.tb15074.x
Sporer, 2008, Inhaled salbutamol and doping control: effects of dose on urine concentrations, Clin J Sport Med, 18, 282, 10.1097/JSM.0b013e3181705c8c
Sterling, 2011, Dose-related efficacy and optimal once-daily (OD) dosing interval of the long-acting beta2 agonist (LABA), vilanterol trifenatate (VI), in adults with persistent asthma (Abstract), Am J Respir Crit Care Med, 183, A4488
Sue-Chu, 1999, Salmeterol and physical performance at −15 degrees C in highly trained nonasthmatic cross-country skiers, Scand J Med Sci Sports, 9, 48, 10.1111/j.1600-0838.1999.tb00206.x
Sugiyama, 2010, Pharmacological profile of a novel bronchodilator, TEI3252, as bifunctional M3 antagonist and beta2 agonist (Abstract), Am J Respir Crit Care Med, 181, A4436
Svedmyr, 1985, Fenoterol: a β2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects, Pharmacotherapy, 5, 109, 10.1002/j.1875-9114.1985.tb03409.x
Svedmyr, 1996, The use of β2-adrenoceptor agonists in the treatment of bronchial asthma, Pharmacol Toxicol, 78, 3, 10.1111/j.1600-0773.1996.tb00172.x
Tasaka, 1986, Formoterol (Atock®): a new orally active and selective β2-receptor stimulant, Med Actual, 22, 505
Timmer, 2010, Single doses of LAS100977, a novel long acting β2-agonist, show high activity and long duration in healthy subjects (Abstract), Am J Respir Crit Care Med, 181, A5663
Tjørhom, 2007, Effects of formoterol on endurance performance in athletes at an ambient temperature of −20 degrees C, Scand J Med Sci Sports, 17, 628, 10.1111/j.1600-0838.2006.00628.x
Tweel, 1971, TH1165a, a new bronchodilator: a clinical comparative evaluation with metaproterenol, Ann Allergy, 29, 142
United States Food and Drug Administration, Division of Pulmonary-Allergy Drugs Advisory Committee and Office of Surveillance and Epidemiology (2009) Clinical briefing document. NDA no. 21-395. Spiriva HandiHaler. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190463.pdf .
van Noord, 1998, A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction, Respir Med, 92, 1346, 10.1016/S0954-6111(98)90140-8
Voss HP (1994) Long-acting β2-adrenoceptor agonists in asthma: molecular pharmacological aspects. Doctoral thesis, Vrije Universiteit, Amsterdam.
Wagner, 1978, Ventilation–perfusion inequality in asymptomatic asthma, Am Rev Respir Dis, 118, 511
Waldeck, 1976, An in vitro method for the study of β-receptor mediated effects on slow contracting skeletal muscle, J Pharm Pharmacol, 28, 434, 10.1111/j.2042-7158.1976.tb04649.x
Wang, 2011, Addition of theophylline or increasing the dose of inhaled corticosteroid in symptomatic asthma: a meta-analysis of randomized controlled trials, Yonsei Med J, 52, 268, 10.3349/ymj.2011.52.2.268
Ward, 1993, Theophylline—an immunomodulatory role in asthma?, Am Rev Respir Dis, 147, 518, 10.1164/ajrccm/147.3.518
Wasserman, 1974, Cardiovascular and bronchomotor responses to selective beta adrenergic receptor agonists in the anesthetized dog, J Pharmacol Exp Ther, 189, 445
Woodcock, 2009, Single dose budesonide/carmoterol fixed combination improves lung function over 24 hours in patients with moderate to severe persistent asthma (Abstract), Eur Respir J, 34, 776s
Wright, 2010, PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist in the anaesthetised dog model of bronchoconstriction (Abstract), Eur Respir J, 24, 1014s
Yamamoto, 2002, Mutation screening of the muscarinic m2 and m3 receptor genes in asthmatics, outgrow subjects, and normal controls, Ann Genet, 45, 109, 10.1016/S0003-3995(02)01128-0
Yasui, 2000, Theophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism, J Leukoc Biol, 67, 529, 10.1002/jlb.67.4.529
Yohannes, 2011, Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes, Respir Care, 56, 477, 10.4187/respcare.00852
Young, 2011, AZD3199: a potent and selective beta2-adrenergic receptor agonist with rapid onset of action (Abstract), Am J Respir Crit Care Med, 183, A1585
Young, 2011, The in vivo profile of AZD3199: a novel, fast acting β2-agonist with a long duration of action (Abstract), Am J Respir Crit Care Med, 183, A1586
Yung, 1998, Randomised controlled trial of aminophylline for severe acute asthma, Arch Dis Child, 79, 405, 10.1136/adc.79.5.405